Tests home monitoring with wearable devices in children with heart failure
Checks whether home monitoring with wearable devices works for children with heart failure.
Plain-language title generated from the registry record
Registry title: WeRoaM: Wearable Remote Monitoring in Heart Failure
Key facts
- Where
- Edmonton, Montreal, Toronto, and Vancouver, CanadaSee the 4 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 8 and 18 years old?
Source: NCT06969560, who can take part
Where in Canada
- Stollery Children'S HospitalEdmonton, CanadaTaking people
- CHU Sainte-JustineMontreal, CanadaNot yet recruiting
- The Hospital for Sick ChildrenToronto, CanadaNot yet recruiting
- BC Children ' s HospitalVancouver, CanadaNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Alberta
- Trial code
- NCT06969560
- Record updated
- 11 May 2026
- Original description
Remote physiologic monitoring (RPM) of heart failure (HF) patients with a virtual platform is well established in adult care. However, this technology remains untested in pediatrics and care continues to rely on a hospital-based model which presents challenges in providing equitable access to care for those with lower socio-economic status or living remotely. Telemonitoring technology tailored for children with machine-based algorithms to predict deterioration is needed to facilitate the equitable provision of safe, home-based care, especially in vulnerable populations.Read full original descriptionShow less
There's No Place Like Home…Feasibility of Remote Physiological Monitoring in Childhood Heart Failure
Remote physiologic monitoring (RPM) of heart failure (HF) patients with a virtual platform is well established in adult care. However, this technology remains untested in pediatrics and care continues to rely on a hospital-based model which presents challenges in providing equitable access to care for those with lower socio-economic status or living remotely. Telemonitoring technology tailored for children with machine-based algorithms to predict deterioration is needed to facilitate the equitable provision of safe, home-based care, especially in vulnerable populations.
This study will enroll 100 pediatric outpatients with or at risk of deteriorating HF from 4 tertiary pediatric heart failure care centres in Canada. We will use a wearable Bluetooth enabled textile (Skiin device), developed by Myant Inc (Toronto, ON), that can monitor heart rate, heart rhythm, respiratory rate and activity, together with additional home-based monitoring of blood pressure (BP), oxygen saturations and weight. The smart textile will be paired to an RPM platform, SphygmoTM (mmHG Inc).
The goal of this project is to assess the feasibility and acceptability of RPM in pediatrics and validate a RPM-based risk prediction model for pediatric HF patients.
Inclusion: Patients from 8-18 years of age who are outpatients at time of study enrollment; Patients with a chest size of at least 69.85 cm in perimeter/circumference (as measured under the pectoral muscles); Patients at-risk for heart failure and with American Heart Association (AHA) Stage B-D Heart Failure will be included in this study irrespective of heart failure medication use; HF etiologies include: congenital cardiac malformation with systemic ventricular systolic dysfunction, idiopathic cardiomyopathy, familial/inherited and/or genetic cardiomyopathy, history of myocarditis with persistent ventricular dysfunction, neuromuscular disorder, inborn error of metabolism, mitochondrial disorder, acquired (chemotherapy, iatrogenic, infection, rheumatic, or nutritional), ischemic (e.g., Kawasaki disease and post-operative HF), and left ventricular non-compaction, restrictive cardiomyopathy and HCM with systolic or diastolic dysfunction.
Exclusion: Patients within 3 months of a surgery; Inability to use technology due to physical or cognitive impairment in the patient or caregiver; Patients who have an implantable cardiac defibrillator or pacemaker; Patients supported by ventricular assist device at study onset; Non-English speaking; Patients whose chest size is too large or small to fit available sizes of the Skiin device.